Author: healthadmin

Three out of ten children and adolescents in Brazil complain of musculoskeletal pain (affecting bones, ligaments, and muscles). This common problem affects the lives of these people and should not be underestimated. This condition, known as disabling musculoskeletal pain, can cause children and adolescents to miss school and abandon daily activities and leisure activities, even though it is not related to trauma, repetitive strain, or any other specific cause. Research published in March in JJournal of Orthopedics and Sports Physiotherapy A study of 694 children and adolescents showed that 86% of people with disabling musculoskeletal pain recovered within 18 months.…

Read More

In a recently published study, Current molecular pharmacology discovered a novel mechanism by which long non-coding RNA PVT1 and translation initiation factor EIF4A1 cooperate to promote gastric cancer metastasis. Researchers showed that PVT1 binds to the N-terminal domain of EIF4A1 and that this interaction leads to increased expression of the secreted glycoprotein STC1. Elevated STC1 activates the Notch1 signaling pathway, promotes epithelial-mesenchymal transition, and significantly promotes tumor cell migration, invasion, and proliferation. Using 4D‑DIA quantitative proteomics and mass spectrometry, the research team identified STC1 as a key downstream effector of the PVT1/EIF4A1 axis. Immunohistochemical analysis of 183 gastric cancer tissues…

Read More

New research has revealed that a very specific form of electrical and magnetic brain stimulation can directly change people’s perception of whether they are in control of their actions. By targeting different areas on the right side of the brain, the researchers were able to improve or decrease the ability to detect external interference during computerized tasks. The results of this study were published in the journal NeuroImage. Imagine that when you trace a straight line with a pen, the ink appears one inch to the left. Your brain immediately recognizes that the visual result does not match the intended…

Read More

Research led by the Rourke Center for Trophoblast Research at the University of Cambridge has shown that single genes in human embryonic cells can be changed using genome editing techniques, allowing researchers to study the very early stages of human development in unparalleled detail. This technology, called base editing, is a more precise version of the genome editing technology CRISPR/Cas9. It has the potential to alter single nucleotide base pairs (the basic building blocks of DNA) within the approximately 3 billion base pair human genome. Researchers used base editing to block a gene called NANOG in very early-stage human embryos…

Read More

Two micrograms is an almost unimaginably small amount. Its weight is less than a small piece of a grain of table salt. However, adults only need this amount of vitamin B12 each day, depending on the guidelines used, to support red blood cells, nerves, and DNA production. 2026 marks 100 years since George Minott and William Murphy reported that a liver-rich diet could treat pernicious anemia, a deadly disease at the time. Their research transformed medicine, eventually leading scientists to identify vitamin B12 as a substance in the liver that treats disease. However, the path to breakthrough began with an…

Read More

“Peacemaker” immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune tolerance, a paper published in December 2016 said. frontiers of science. Inflammation is increasingly being cited as a cause of a wide range of diseases, from cancer, diabetes and chronic infections to cardiovascular, neurodegenerative and reproductive diseases. Immune cells called regulatory T cells (Tregs) were originally defined as “suppressor” cells that prevent other immune cells from attacking the body, but are eventually being studied as “living drugs” that can be adapted to target many diseases that have an inflammatory component. Such approaches aimed…

Read More

The Supreme Court’s decision to protect Roundup herbicide makers from cancer lawsuits is the latest in a series of rulings that the Coalition to Bring America Back to Health could hurt Republicans at the polls in November. In a 7-2 decision Thursday, the nation’s highest court, encouraged by the Trump administration, reached an agreement with Bayer that federal law would prevent Roundup users from suing in state courts for failing to warn customers that the product’s active ingredient, glyphosate, could lead to cancer. The Supreme Court’s decision closes the door on thousands of failure-to-warn lawsuits in state courts across the…

Read More

Upside, a scalable housing stability platform, has raised $20 million in a Series A funding round to continue addressing the U.S. housing crisis from a healthcare perspective. Aquiline led the round, with participation from Flare Capital Partners and support from existing investors 645 Ventures, Freestyle Capital, Triple Impact Capital, and Techstars. Housing instability is “one of the most persistent drivers of avoidable health care costs,” Dante La Ruffa, partner and head of venture and growth strategy at Aquiline, said in a statement. “Upside has the model, team, and infrastructure to address that, and we’re excited to partner with them in…

Read More

WASHINGTON – The Supreme Court on Thursday sided with the makers of the weedkiller Roundup and is expected to block thousands of lawsuits alleging they failed to warn people the product could cause cancer. The case came before the judge after a wave of litigation, including a multibillion-dollar judgment against global pesticide manufacturer Bayer. Bayer is a Germany-based company that acquired Roundup in 2018 when it acquired original producer Monsanto. The decision is a victory for President Donald Trump’s administration, but could be politically difficult as allies in the Make America Healthy Again movement want to curb pesticide use. In…

Read More

WASHINGTON — Political appointees appear poised to take more control over the information coming out of the Centers for Disease Control and Prevention under a proposal to add a separate scientific division on top of the agency. The new office, called the Executive Advisory Science and Operations Unit, will review scientific publications such as weekly morbidity and mortality reports for peer-reviewed journals and director general briefings on preparedness activities. He will report directly to Matthew Buzzelli, the agency’s chief of staff. STAT Plus: What stripping civil service protections from thousands of federal employees means for HHS Efforts have been underway…

Read More